tm logo
IMMUNOSCAPE
Live/Registered
REGISTERED

on 28 Apr 2020

Last Applicant/ Owned by

#24-10 Shaw Centre

Singapore

SG

228208

Serial Number

88035450 filed on 12th Jul 2018

Registration Number

6039731 registered on 28th Apr 2020

in the Principal Register

Correspondent Address

Jon Jekel

Jon Jekel Pillsbury Winthrop Shaw Pittman LLP

San Diego, CA 92130

United States

Filing Basis

1. intent to use

2. filed as use application

3. use application currently

Disclaimer

NO DATA

IMMUNOSCAPE

Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multip Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features


First Use Date in General

28th Feb 2017

First Use Date in Commerce

28th Feb 2017

Mark Details


Serial Number

No 88035450

Mark Type

No Service Mark

Attorney Docket Number

No 49741-460721

44D Filed

Yes

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Sep 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
03rd Sep 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03rd Sep 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Sep 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06th Sep 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
06th Sep 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06th Sep 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28th Apr 2020REGISTERED-PRINCIPAL REGISTER
11th Feb 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Feb 2020PUBLISHED FOR OPPOSITION